rs770199753
Variant summary
Our verdict is Likely benign. Variant got -2 ACMG points: 2P and 4B. PM2BP4_Strong
The NM_004320.6(ATP2A1):c.640A>G(p.Ile214Val) variant causes a missense change. The variant allele was found at a frequency of 0.0000186 in 1,613,838 control chromosomes in the GnomAD database, with no homozygous occurrence. In-silico tool predicts a benign outcome for this variant. 13/21 in silico tools predict a benign outcome for this variant. Variant has been reported in ClinVar as Uncertain significance (★★).
Frequency
Consequence
NM_004320.6 missense
Scores
Clinical Significance
Conservation
Genome browser will be placed here
ACMG classification
Verdict is Likely_benign. Variant got -2 ACMG points.
Transcripts
RefSeq
Gene | Transcript | HGVSc | HGVSp | Effect | Exon rank | MANE | Protein | UniProt |
---|---|---|---|---|---|---|---|---|
ATP2A1 | NM_004320.6 | c.640A>G | p.Ile214Val | missense_variant | Exon 8 of 23 | ENST00000395503.9 | NP_004311.1 | |
ATP2A1 | NM_173201.5 | c.640A>G | p.Ile214Val | missense_variant | Exon 8 of 22 | NP_775293.1 | ||
ATP2A1 | NM_001286075.2 | c.265A>G | p.Ile89Val | missense_variant | Exon 6 of 21 | NP_001273004.1 |
Ensembl
Gene | Transcript | HGVSc | HGVSp | Effect | Exon rank | TSL | MANE | Protein | Appris | UniProt |
---|---|---|---|---|---|---|---|---|---|---|
ATP2A1 | ENST00000395503.9 | c.640A>G | p.Ile214Val | missense_variant | Exon 8 of 23 | 1 | NM_004320.6 | ENSP00000378879.5 | ||
ATP2A1 | ENST00000357084.7 | c.640A>G | p.Ile214Val | missense_variant | Exon 8 of 22 | 2 | ENSP00000349595.3 | |||
ATP2A1 | ENST00000536376.5 | c.265A>G | p.Ile89Val | missense_variant | Exon 6 of 21 | 2 | ENSP00000443101.1 | |||
ATP2A1 | ENST00000564732.1 | n.-231A>G | upstream_gene_variant | 5 | ENSP00000457357.1 |
Frequencies
GnomAD3 genomes AF: 0.0000198 AC: 3AN: 151876Hom.: 0 Cov.: 31
GnomAD3 exomes AF: 0.0000638 AC: 16AN: 250790Hom.: 0 AF XY: 0.0000811 AC XY: 11AN XY: 135646
GnomAD4 exome AF: 0.0000185 AC: 27AN: 1461844Hom.: 0 Cov.: 32 AF XY: 0.0000248 AC XY: 18AN XY: 727224
GnomAD4 genome AF: 0.0000197 AC: 3AN: 151994Hom.: 0 Cov.: 31 AF XY: 0.0000269 AC XY: 2AN XY: 74298
ClinVar
Submissions by phenotype
not specified Uncertain:1
- -
Brody myopathy Uncertain:1
In summary, the available evidence is currently insufficient to determine the role of this variant in disease. Therefore, it has been classified as a Variant of Uncertain Significance. Algorithms developed to predict the effect of missense changes on protein structure and function (SIFT, PolyPhen-2, Align-GVGD) all suggest that this variant is likely to be tolerated, but these predictions have not been confirmed by published functional studies and their clinical significance is uncertain. This variant has not been reported in the literature in individuals with ATP2A1-related conditions. ClinVar contains an entry for this variant (Variation ID: 393090). This variant is present in population databases (rs770199753, ExAC 0.09%). This sequence change replaces isoleucine with valine at codon 214 of the ATP2A1 protein (p.Ile214Val). The isoleucine residue is weakly conserved and there is a small physicochemical difference between isoleucine and valine. -
not provided Uncertain:1
The I214V variant has not been published as a pathogenic variant, nor has it been reported as a benign variant to our knowledge. The I214V variant is not observed at a significant frequency in large population cohorts (Lek et al., 2016; 1000 Genomes Consortium et al., 2015; Exome Variant Server). This variant is a conservative amino acid substitution, which is not likely to impact secondary protein structure as these residues share similar properties. However, this substitution occurs at a position that is conserved across species, and in silico analysis is inconsistent in its predictions as to whether or not the variant is damaging to the protein structure/function. -
Computational scores
Source:
Splicing
Find out detailed SpliceAI scores and Pangolin per-transcript scores at